ponesimod

FDA Drug Profile

ponesimod is listed in the FDA National Drug Code directory with 9 NDC codes. Available dosage form: tablet, film coated.

Drug details

Generic Name
ponesimod
Sponsor
Patheon France S.A.S.
NDC Codes
9
Dosage Forms
TABLET, FILM COATED
Active Ingredients
PONESIMOD

Indications and Usage

1 INDICATIONS AND USAGE PONVORY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. PONVORY is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.